David Liu and Jennifer Doudna talk with our Senior Editor Markus Elsner about the state of the genome editing field and what challenges remain, especially as various therapies are now entering the clinic. This episode is part of
Nature Biotechnology’s Focus issue on CRISPR tools and therapies.
Hosted on Acast. See acast.com/privacy for more information.
